Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands
暂无分享,去创建一个
M. Natália D. S. Cordeiro | Maykel Cruz-Monteagudo | Eduardo Tejera | Orazio Nicolotti | Jean-Louis Mergny | Miguel Ángel Cabrera-Pérez | Teresa M. Garrigues | Cesar Paz-y-Miño | Fernanda Borges | Daimel Castillo-González | Aurore De Rache | Gisselle Pérez-Machado | Antonellina Introcaso | Giuseppe Mangiatordi | Aurore Guédin | Anne Bourdoncle | Federico Pallardó | F. Pallardó | M. Cruz-Monteagudo | M. Cordeiro | J. Mergny | E. Tejera | A. Bourdoncle | G. Mangiatordi | C. Paz-y-Miño | O. Nicolotti | M. Cabrera-Pérez | T. Garrigues | Daimel Castillo-González | A. Guédin | G. Pérez-Machado | Antonellina Introcaso | A. D. Rache | Fernanda Borges
[1] D. Horvath,et al. ISIDA Property‐Labelled Fragment Descriptors , 2010, Molecular informatics.
[2] Stefano Alcaro,et al. Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches. , 2013, Journal of medicinal chemistry.
[3] Hugo Kubinyi,et al. Virtual Screening - The Road to Success , 2006 .
[4] J. Shay,et al. Role of telomeres and telomerase in cancer. , 2011, Seminars in cancer biology.
[5] Nathalie Japkowicz,et al. The Class Imbalance Problem: Significance and Strategies , 2000 .
[6] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[7] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[8] Jean-Louis Mergny,et al. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. , 2002, Cancer research.
[9] Fuhui Long,et al. Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[10] Ian H. Witten. Chapter 5 – Credibility: Evaluating What's Been Learned , 2011 .
[11] Stephen Neidle,et al. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells. , 2010, Methods in molecular biology.
[12] Emilio Benfenati,et al. REACH and in silico methods: an attractive opportunity for medicinal chemists. , 2014, Drug discovery today.
[13] D. Corey. Telomeres and telomerase: from discovery to clinical trials. , 2009, Chemistry & biology.
[14] Reema Gabrani,et al. Recent patents on anti-telomerase cancer therapy. , 2012, Recent patents on anti-cancer drug discovery.
[15] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[16] J. Mergny,et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] Anne Mai Wassermann,et al. SARANEA: A Freely Available Program To Mine Structure-Activity and Structure-Selectivity Relationship Information in Compound Data Sets , 2010, J. Chem. Inf. Model..
[18] J. Riou,et al. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands. , 2009, European journal of medicinal chemistry.
[19] Salvatore Florio,et al. Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands. , 2011, Bioorganic & medicinal chemistry.
[20] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[21] Patrick Mailliet,et al. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. , 2004, Biochemical and biophysical research communications.
[22] Jean-Louis Mergny,et al. FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA. , 2013, Current pharmaceutical design.
[23] Ettore Novellino,et al. Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders. , 2009, Journal of the American Chemical Society.
[24] Stephen Neidle,et al. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. , 2006, Journal of medicinal chemistry.
[25] Julie Clark,et al. Discovery of Novel Antimalarial Compounds Enabled by QSAR-Based Virtual Screening , 2013, J. Chem. Inf. Model..
[26] Kenoki Ohuchida,et al. Quantitative Assessment of Telomerase Activity and Human Telomerase Reverse Transcriptase Messenger RNA Levels in Pancreatic Juice Samples for the Diagnosis of Pancreatic Cancer , 2005, Clinical Cancer Research.
[27] et al.,et al. The RNA component of human telomerase , 1995, Science.
[28] Stephen Muggleton,et al. Support vector inductive logic programming outperforms the naive Bayes classifier and inductive logic programming for the classification of bioactive chemical compounds , 2007, J. Comput. Aided Mol. Des..
[29] Markus Kaiser,et al. Fluorescence-based melting assays for studying quadruplex ligands. , 2007, Methods.
[30] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[31] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[32] R. Guha. The ups and downs of structure-activity landscapes. , 2011, Methods in molecular biology.
[33] Maykel Cruz-Monteagudo,et al. Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? , 2014, Drug discovery today.
[34] Roberto Todeschini,et al. Molecular descriptors for chemoinformatics , 2009 .
[35] Ding Li,et al. Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA. , 2012, European journal of medicinal chemistry.
[36] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[37] Stefano Alcaro,et al. Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations , 2014, Molecules.
[38] Stephen Neidle,et al. Mechanism of acridine-based telomerase inhibition and telomere shortening. , 2007, Biochemical pharmacology.
[39] R. Polikar,et al. Ensemble based systems in decision making , 2006, IEEE Circuits and Systems Magazine.
[40] Charles R. Cantor,et al. Oligonucleotide interactions. III. Circular dichroism studies of the conformation of deoxyoligonucleolides , 1970 .
[41] Frank R. Burden,et al. Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks , 2000, J. Chem. Inf. Comput. Sci..
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] Oscar Méndez-Lucio,et al. Identifying Activity Cliff Generators of PPAR Ligands Using SAS Maps , 2012, Molecular informatics.
[44] Subhash C. Bagui,et al. Combining Pattern Classifiers: Methods and Algorithms , 2005, Technometrics.
[45] Simona Distinto,et al. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? , 2008, J. Comput. Aided Mol. Des..
[46] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[47] C R Cantor,et al. Oligonucleotide interactions. 3. Circular dichroism studies of the conformation of deoxyoligonucleotides. , 1970, Biopolymers.
[48] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[49] Cheng-Chung Chang,et al. Induction of senescence in cancer cells by the G‐quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity , 2012, British journal of pharmacology.
[50] Maykel Cruz-Monteagudo,et al. Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance? , 2014, Molecular Diversity.
[51] Shuo-Bin Chen,et al. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA. , 2010, Bioorganic & medicinal chemistry.
[52] Nina Nikolova-Jeliazkova,et al. QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review , 2005, Alternatives to laboratory animals : ATLA.
[53] B. Herbert,et al. Pharmaceutical regulation of telomerase and its clinical potential , 2011, Journal of cellular and molecular medicine.
[54] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[55] Stephen Neidle,et al. Molecular modeling and simulation of G-quadruplexes and quadruplex-ligand complexes. , 2010, Methods in molecular biology.
[56] Christophe Guilbert,et al. Discovery of ligands for a novel target, the human telomerase RNA, based on flexible-target virtual screening and NMR. , 2008, Journal of medicinal chemistry.
[57] Alexander Golbraikh,et al. Combinatorial QSAR of Ambergris Fragrance Compounds , 2004, J. Chem. Inf. Model..
[58] Hyun Cheol Chung,et al. Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients. , 2005, International journal of molecular medicine.
[59] Ram Krishna Thakur,et al. Genome-wide computational and expression analyses reveal G-quadruplex DNA motifs as conserved cis-regulatory elements in human and related species. , 2008, Journal of medicinal chemistry.
[60] Stephen Neidle,et al. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. , 2010, Journal of the American Chemical Society.
[61] Tom Brown,et al. High throughput measurement of duplex, triplex and quadruplex melting curves using molecular beacons and a LightCycler. , 2002, Nucleic acids research.
[62] Imrich Géci,et al. Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells. , 2009, Journal of medicinal chemistry.
[63] T Scior,et al. How to recognize and workaround pitfalls in QSAR studies: a critical review. , 2009, Current medicinal chemistry.
[64] Stefano Alcaro,et al. Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach , 2013, Molecules.
[65] D. Bearss,et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[66] T. C. Jenkins,et al. DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition. , 2001, Mini reviews in medicinal chemistry.
[67] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[68] Jürgen Bajorath,et al. Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.
[69] Zheng Tan,et al. Contribution of telomere G-quadruplex stabilization to the inhibition of telomerase-mediated telomere extension by chemical ligands. , 2011, Journal of the American Chemical Society.
[70] Igor V. Tetko,et al. ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions , 2012, J. Chem. Inf. Model..
[71] Claudia Sissi,et al. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer. , 2010, Biochemical pharmacology.
[72] Kah Wai Lim,et al. Coexistence of two distinct G-quadruplex conformations in the hTERT promoter. , 2010, Journal of the American Chemical Society.
[73] A. Goldkorn,et al. Telomerase targeted therapy in cancer and cancer stem cells. , 2011, Clinical advances in hematology & oncology : H&O.
[74] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[75] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[76] R. Todeschini,et al. Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .
[77] Ding Li,et al. Pharmacophore-based discovery of triaryl-substituted imidazole as new telomeric G-quadruplex ligand. , 2011, Bioorganic & medicinal chemistry letters.
[78] Leo Breiman,et al. Classification and Regression Trees , 1984 .
[79] Alexander Tropsha,et al. Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..
[80] Ludmila I. Kuncheva,et al. Combining Pattern Classifiers: Methods and Algorithms , 2004 .
[81] I. Tetko,et al. ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors , 2008 .
[82] M. Björkholm,et al. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. , 2001, Clinical chemistry.
[83] Rajarshi Guha,et al. Structure—Activity Landscape Index: Identifying and Quantifying Activity Cliffs. , 2008 .
[84] N. Japkowicz. Learning from Imbalanced Data Sets: A Comparison of Various Strategies * , 2000 .
[85] Igor V. Tetko,et al. Applicability Domains for Classification Problems: Benchmarking of Distance to Models for Ames Mutagenicity Set , 2010, J. Chem. Inf. Model..
[86] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[87] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[88] J. Mergny,et al. Fluorescence Resonance Energy Transfer as a Probe for G‐Quartet Formation by a Telomeric Repeat , 2001, Chembiochem : a European journal of chemical biology.
[89] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[90] อนิรุธ สืบสิงห์,et al. Data Mining Practical Machine Learning Tools and Techniques , 2014 .
[91] D. Young,et al. Are the Chemical Structures in Your QSAR Correct , 2008 .
[92] Stephen Neidle,et al. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. , 2004, Molecular cancer therapeutics.
[93] Henning Wege,et al. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. , 2002, Nucleic acids research.
[94] Lin Li,et al. Fast screening and structural elucidation of G-quadruplex ligands from a mixture via G-quadruplex recognition and NMR methods. , 2009, Biochimie.
[95] Lin Li,et al. Screening potential antitumor agents from natural plant extracts by G-quadruplex recognition and NMR methods. , 2008, Angewandte Chemie.
[96] Stephen Neidle,et al. The design of G-quadruplex ligands as telomerase inhibitors. , 2003, Mini reviews in medicinal chemistry.